Eleonora Rozmarin
Adult Health · Brooklyn, NYNPI 1568906337
Payments from drug & device makers
Across 287 payments — averaging $27.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novartis$773
- AbbVie$680
- Novo Nordisk$637
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$578
- Boehringer Ingelheim$447
- plus $3K from 31 others
What the payments were for
- Food & beverage$7,45795%
- Education$3525%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 49 | $1,504 |
| Novartis | 37 | $773 |
| AbbVie | 36 | $680 |
| Novo Nordisk | 20 | $637 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 34 | $578 |
| Boehringer Ingelheim | 6 | $447 |
| Oyster Point Pharma, Inc. | 14 | $326 |
| Bayer | 3 | $275 |
| OPKO Pharmaceuticals, LLC | 13 | $263 |
| Lilly USA, LLC | 5 | $222 |
| AstraZeneca | 7 | $159 |
| Otsuka America Pharmaceutical, Inc. | 6 | $157 |
| Medtronic | 1 | $152 |
| Aimmune Therapeutics, Inc. | 5 | $140 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Antares Pharma, Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| Amarin Pharma, Inc. | 5 | $107 |
| Ironwood Pharmaceuticals, Inc | 4 | $90 |
| Sanofi-aventis U.S. LLC | 1 | $89 |
| Bausch & Lomb Americas Inc. | 4 | $77 |
| Thea Pharma Inc. | 3 | $71 |
| Ardelyx, Inc. | 3 | $71 |
| Akebia Therapeutics Inc | 3 | $68 |
| Nestle Healthcare Nutrition Inc. | 3 | $67 |
| Shield Therapeutics Inc | 3 | $57 |
| Alcon | 2 | $50 |
| Eyevance Pharmaceuticals LLC | 2 | $44 |
| GSK | 2 | $42 |
| Merck | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Optinose US, Inc. | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $17 |
| Acclarent, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,810 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 254 | $307,524 |
| ZenpepLipase/Protease/Amylase | 136 | $187,022 |
| CreonLipase/Protease/Amylase | 68 | $90,052 |
| LinzessLinaclotide | 161 | $84,079 |
| OzempicSemaglutide | 88 | $82,770 |
| JardianceEmpagliflozin | 121 | $74,270 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 51 | $67,823 |
| Metformin Er GastricMetformin Hcl | 121 | $59,286 |
| VascepaIcosapent Ethyl | 167 | $58,169 |
| MeloxicamMeloxicam, Submicronized | 100 | $38,711 |
| Dexlansoprazole DrDexlansoprazole | 238 | $38,131 |
| Diclofenac Epolamine | 59 | $36,282 |
| ProliaDenosumab | 17 | $29,096 |
| Repatha SureclickEvolocumab | 40 | $27,586 |
| NamzaricMemantine Hcl/Donepezil Hcl | 48 | $27,156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess, Namzaric, Restasis, Synthroid | $680 | $223,613379 claims |
| Aimmune Therapeutics, Inc.Zenpep | $140 | $187,022136 claims |
| Novo NordiskOzempic, Rybelsus | $637 | $100,038101 claims |
| Boehringer IngelheimJardiance, Tradjenta | $447 | $86,888146 claims |
| MerckJanumet, Januvia | $36 | $33,28561 claims |
| AmgenProlia | $1,504 | $29,09617 claims |
| GSKBreo Ellipta | $42 | $20,64053 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $578 | $9,90618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Brooklyn
- Huiwen YingBrooklyn$17K
- Joyce YeungBrooklyn$15K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.